Engimata has a patented platform adjuvant technology that improves vaccine efficiency, reduces antigen dose and enhances vaccine stability outside the cold supply chain.
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
